in prevalence in the EA was statistically significant (For men: 55.4% [47.9-54.1] vs. 51.1% [52.2-58.6]; for women: 28.1 [25.4-30.9] vs. 25.1% [22.6-27.9]) while the estimates in AA subjects could be equated across diagnostic classification scheme (For men: 52.6% [48.3-56.9] vs. 52.6 [47.2-55.8]; for women: 30.2% [26.2-34.4] vs. 31.8% [27.7-36.1].
